BMRN vs GMED · P/E 40, rev $1.76B vs P/E 42, rev $1.55B
Biomarin Pharmaceutical Inc (BMRN) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the BMRN and GMED stock pages for the full models.
Not investment advice.